Department of Experimental Immunology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
Department of Experimental Immunology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
Department of Experimental Immunology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
Department of Experimental Immunology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
Department of Experimental Immunology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
Department of Experimental Immunology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
Osaka Research Laboratory, Benesis Corporation, Osaka, Japan
Department of Experimental Immunology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
Department of Genetics, University of Erlangen, Erlangen, Germany
Department of Experimental Immunology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
Copyright © 2012 Jun Tanaka, Kumiko Hirano, Yuzuru Sakamoto, Akiko Sugahara-Tobinai, Shota Endo, Yumi Ito-Matsuoka, Atsushi Nakano, Masanori Inui, Lars Nitschke, Toshiyuki Takai et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Tanaka, J. , Hirano, K. , Sakamoto, Y. , Sugahara-Tobinai, A. , Endo, S. , Ito-Matsuoka, Y. , Nakano, A. , Inui, M. , Nitschke, L. and Takai, T. (2012) Intravenous immunoglobulin suppresses IL-10 production by activated B cells in vitro.
Open Journal of Immunology,
2, 149-160. doi:
10.4236/oji.2012.24019.